Every month, thousands of dog owners forget a heartworm pill — and thousands more assume their dog is protected when they’re not. ProHeart changes that calculus entirely: one injection at the vet’s office, and your dog is continuously protected for six months or a full year. But the injection format raises real questions that monthly pills don’t — about safety, about what happens if your dog reacts, about which dogs should never get it. This guide covers the facts, straight from the FDA label, peer-reviewed clinical studies, and the questions vets hear most.
Most people searching for ProHeart information are trying to decide whether to say yes at their next vet appointment — or already said yes and are now worried. These are the honest answers to both situations.
Understanding what’s happening inside your dog’s body after an injection makes the safety considerations, the timing requirements, and the contraindications make more sense — rather than feeling like a list of arbitrary rules.
Moxidectin is a semi-synthetic macrocyclic lactone — a class of drugs that includes ivermectin and milbemycin. It works by enhancing the activity of glutamate-gated chloride channels and GABA receptors in invertebrate nervous systems, causing paralysis and death in susceptible parasites. Heartworm larvae (the stage called L3 and L4, which are the ones mosquitoes deposit and which circulate in your dog’s tissue before maturing into adults) are rapidly paralyzed and eliminated. Moxidectin does not kill adult heartworms — it only kills the larval stages that arrived since the last dose or injection. This is true of all heartworm preventives, not just ProHeart.
What makes ProHeart unique is not the drug — it’s the delivery. Moxidectin is encased in microspheres made of glyceryl tristearate (a fat) and hydroxypropyl methylcellulose. When injected subcutaneously (under the skin, typically at the scruff of the neck or between the shoulder blades), the microspheres are taken up by adipose tissue — your dog’s fat-storing connective tissue. The fat in those microspheres is slowly metabolized over months, releasing moxidectin at a steady, low-level therapeutic rate the entire time. There is no peak-and-trough dosing cycle. Unlike a monthly pill, which delivers a spike of drug that then clears from the body, ProHeart maintains a consistent moxidectin level — meaning there is no vulnerable window at the end of a dosing cycle where undetected larvae could begin maturing.
Heartworm disease (Dirofilaria immitis) is spread exclusively by infected mosquitoes. When a mosquito carrying third-stage larvae (L3) bites a dog, those larvae enter the skin and migrate through tissue over the next several months, maturing into adult worms that ultimately live in the pulmonary arteries and heart. Adult female heartworms can grow to 12 inches in length. The damage they cause — vessel inflammation, pulmonary hypertension, right-sided heart failure — accumulates over time and is often irreversible. Treatment is expensive ($1,000–$1,500+ or more), requires exercise restriction for months, and carries its own risks. Heartworm disease has been documented in all 50 states. Prevention at any price point is a substantially better outcome than treatment.
Two formulations, same drug, different concentrations and durations. The choice isn’t always as simple as “pick the longer one.”
ProHeart 6 delivers moxidectin at 0.17 mg/kg body weight and provides 6 months of continuous heartworm prevention. It is FDA-approved for dogs 6 months of age and older — making it the only ProHeart option available for puppies who have completed their initial series and are ready for heartworm prevention but aren’t yet old enough for ProHeart 12. ProHeart 6 also treats existing larval and adult hookworm infections (Ancylostoma caninum and Uncinaria stenocephala) at the time of injection — a meaningful bonus for dogs in areas with heavy hookworm exposure. The 6-month duration also gives vets a natural check-in point: if a dog tolerates the first injection well, the conversation at the 6-month visit can be whether to continue with ProHeart 6 or transition to ProHeart 12.
ProHeart 12 delivers moxidectin at 0.5 mg/kg — three times the concentration of ProHeart 6 — and is the only FDA-approved product providing a full year of heartworm prevention with a single injection. FDA approval came in July 2019 following three efficacy studies demonstrating 100% effectiveness, plus comprehensive safety studies including an ivermectin-sensitive Collie safety trial. ProHeart 12 is approved for dogs 12 months and older. The higher moxidectin concentration is the reason the age minimum is stricter — the drug was not evaluated in dogs under 12 months. In Australia and New Zealand, an equivalent product (ProHeart SR-12) has been the leading heartworm preventive for nearly two decades, providing a long real-world safety dataset that informed the US approval. Like ProHeart 6, it also treats existing hookworm infections at the time of injection.
- Dog under 12 months old? ProHeart 6 is the only option — wait until 12 months for ProHeart 12 if annual dosing is the goal.
- First time with ProHeart? Some vets prefer starting with ProHeart 6 so any adverse reaction — while not reversible — at least reflects a lower dose and a 6-month rather than 12-month commitment at that moxidectin level.
- Dog with a strong compliance track record and clean health history? ProHeart 12 at the annual wellness visit is the most convenient option — one injection covers the whole year, aligning neatly with the annual heartworm test and exam.
- Dog with a seasonal mosquito environment only? ProHeart 6 can be timed to provide coverage only during high-exposure months in climates with true winters. ProHeart 12 makes more sense for year-round mosquito regions.
The side effect question is the one that generates the most anxiety online. Here is the full, accurate picture — including what the FDA label says, what the field study found, and what the irreversibility of an injection actually means in practice.
In the field study comparing ProHeart 12 to 20 monthly doses of Heartgard Plus in 593 client-owned dogs, adverse events occurred at similar rates in both groups. The most frequently reported effects were vomiting, diarrhea, and reduced appetite — and the vast majority were mild and self-resolving within 24–48 hours. Many dogs show no effects at all. Mild injection-site swelling or itching is also common and typically resolves within a few days. The critical reassurance from the clinical data: for healthy dogs meeting the label criteria, the safety profile is broadly comparable to the monthly oral alternatives most owners already use.
The full adverse event list from the ProHeart FDA label, based on post-approval experience reporting, includes:
- Immune/allergic: anaphylaxis, anaphylactoid reactions, urticaria (hives), head and facial edema, pale mucous membranes, cardiovascular collapse, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia
- Gastrointestinal: vomiting with or without blood, bloody diarrhea, hypersalivation
- General: depression, lethargy, anorexia, fever, weight loss, weakness
- Neurological: seizures, ataxia, trembling, hind limb paresis
- Dermatological: injection site pruritus, swelling, erythema multiforme
Context matters: not all adverse events reported post-approval are definitively caused by the drug — the label notes it is not always possible to establish causation from spontaneous reports. Serious reactions are rare, but they are real enough that the FDA requires veterinarians to complete a certification process before they can order and administer ProHeart, and to provide owners with a Client Information Sheet at every visit.
The single most important concept to understand about any injectable extended-release drug: if your dog has an adverse reaction to a monthly heartworm pill, you stop giving it and the drug clears the body in days. If your dog has an adverse reaction to ProHeart, you can treat the reaction — antihistamines, epinephrine, corticosteroids, and supportive care as appropriate — but you cannot remove the moxidectin already deposited in the fat tissue. The drug will continue to release for weeks to months. This is not a reason to avoid ProHeart for healthy, eligible dogs — it is a reason to make absolutely sure your dog is a good candidate before the injection, and to stay for observation afterward. Treating a reaction quickly leads to recovery in the vast majority of cases.
The most serious hypersensitivity reactions — anaphylaxis, cardiovascular collapse — happen within the first hour and most commonly within the first 30–60 minutes. Staying at the veterinary clinic for at least 20–30 minutes after the injection is the single most practical safety measure an owner can take. If a serious reaction begins while you are still at the clinic, the team can respond immediately with epinephrine and supportive care. If it begins 2 hours into your drive home on a rural highway, the outcome depends on how quickly you can reach emergency care. Ask your vet whether they recommend staying for observation — and if you have a dog with a pre-existing allergy history, make a plan before the day of the injection.
The FDA label’s contraindications and cautions exist because specific dogs had specific problems in clinical testing. These aren’t bureaucratic boilerplate — they reflect real safety data.
- Dogs that are sick, debilitated, or underweight at the time of injection. The label is explicit: ProHeart should not be given to dogs in compromised condition. In clinical studies, two geriatric dogs with a history of weight loss died within a month of a second ProHeart 6 injection, and a third underweight dog died 3 months after the first. Bodyweight, body condition, and health status matter.
- Dogs with a history of unexplained weight loss. Unexplained weight loss is a red flag for underlying disease that may impair drug metabolism and increase adverse event risk. The label specifically includes this as a contraindication.
- Dogs previously found to be hypersensitive to moxidectin. If your dog reacted to a prior ProHeart injection or to another moxidectin product (Advantage Multi, Bravecto Plus for cats), ProHeart is contraindicated.
- Dogs with active heartworm infection. Moxidectin rapidly kills microfilariae, triggering a severe inflammatory response in positive dogs. A heartworm antigen test is required before every administration.
- Dogs younger than 6 months (ProHeart 6) or 12 months (ProHeart 12). Safety and efficacy have not been evaluated in younger animals at the respective approved doses.
- Dogs with pre-existing allergic disease — food allergy, environmental atopy, flea allergy dermatitis. These dogs have a sensitized immune system with elevated baseline hypersensitivity risk. Not disqualifying, but requires explicit discussion about timing, monitoring, and whether the allergy is currently controlled.
- Dogs being vaccinated on the same day. The FDA label specifically warns about concurrent vaccination, citing reported anaphylaxis cases following ProHeart plus vaccine administration on the same visit. Many vets separate these by 2–4 weeks as a precaution.
- Collie breeds and MDR1/ABCB1 mutation carriers — including Collies, Australian Shepherds, Shetland Sheepdogs, Border Collies, and mixed breeds with significant herding dog ancestry. The margin of safety study found no adverse effects in ivermectin-sensitive Collies at up to 5X the label dose — genuine reassurance, but genetic testing before a first injection provides additional individual data.
- Dogs with a history of seizures. Moxidectin has CNS activity and seizures appear on the adverse event list. Dogs with epilepsy or prior seizure history warrant careful individualized assessment before ProHeart is used.
- Senior dogs over 8–10 years old. Age alone is not a contraindication, but geriatric dogs are more likely to have underlying conditions that affect drug metabolism. A thorough pre-injection exam and recent bloodwork is particularly important for older dogs.
The ProHeart certification program — a Zoetis requirement for any veterinary practice ordering ProHeart — ensures every clinic understands six key safety points before administering the drug. Additionally, the FDA label requires a veterinarian to: assess the patient’s health through a thorough history and physical examination; test for existing heartworm infection; provide the Client Information Sheet to the owner and review it; and assess diagnostic testing as indicated before each injection. If a vet proposes giving ProHeart without a heartworm test, without taking a health history, or without reviewing the Client Information Sheet with you — those are red flags worth raising.
This comparison reflects the most common alternatives for heartworm prevention in the United States. Coverage, compliance data, and other features are based on FDA-approved label indications and published research.
| Product | Duration | Delivery | Heartworm | Hookworm | Fleas/Ticks | Other Parasites | Annual Compliance | Est. Annual Cost |
|---|---|---|---|---|---|---|---|---|
| ProHeart 6 | 6 months | Injection | ✓ 100% | ✓ Yes | ✗ None | ✗ None | High (injection) | ~$80–$180 (2 doses) |
| ProHeart 12 | 12 months | Injection | ✓ 100% | ✓ Yes | ✗ None | ✗ None | Highest (1 dose/yr) | ~$60–$170 (1 dose) |
| Heartgard Plus | Monthly | Chewable | ✓ High | ✓ Yes | ✗ None | Roundworms only | 24.4% compliance (study) | ~$60–$120 (12 doses) |
| Sentinel Spectrum | Monthly | Chewable | ✓ High | ✓ Yes | ✓ Flea eggs only | Rounds, whips, tapes | Monthly compliance | ~$80–$150 (12 doses) |
| Simparica Trio | Monthly | Chewable | ✓ High | ✓ Yes | ✓ Fleas + ticks | Rounds, whips | Monthly compliance | ~$150–$240 (12 doses) |
| Interceptor Plus | Monthly | Chewable | ✓ High | ✓ Yes | ✗ None | Rounds, whips, tapes | Monthly compliance | ~$70–$130 (12 doses) |
Costs are estimated retail ranges and vary significantly by dog weight, geographic market, and clinic. Annual compliance rates for monthly products from peer-reviewed Frontiers in Veterinary Science study (2021). All products listed are FDA-approved. ProHeart flea/tick and intestinal parasite gaps must be filled with separate products — discuss full parasite prevention plan with your veterinarian.
The right choice depends on your dog’s health history, your lifestyle, and what kind of dog owner you are — not on what the most popular option is.
This is ProHeart’s strongest use case — and the compliance data backs it up. A peer-reviewed study of over 13 million US canine patient records found that injectable moxidectin compliance was 51.7% annually vs. 24.4% for monthly oral prevention. If the pill isn’t happening reliably, your dog isn’t reliably protected. One injection at the vet’s office aligns with a wellness visit that is already scheduled. There’s nothing to hide, nothing to chew, and no reminder app required. For dogs who are healthy and meet the label criteria, switching to ProHeart 12 is a meaningful upgrade in actual real-world protection.
The label identifies allergic disease as a caution — not an absolute bar. The honest conversation to have with your vet includes: whether your dog’s allergies are currently controlled or active, whether the vet plans to administer vaccines the same day (if so, consider separate visits), and whether you can stay 30+ minutes post-injection. If the answers are “controlled,” “no” or “we’ll separate them,” and “yes” — ProHeart is still a reasonable discussion. If your dog is currently flaring badly or has had a recent anaphylactic event from any allergen, this may not be the right timing. Allergies narrow the margin, they don’t eliminate ProHeart as an option for every allergic dog.
The FDA requires vets to provide a Client Information Sheet before every ProHeart injection — specifically so owners understand the adverse event profile before consenting. If this didn’t happen, you are now reading what should have been explained. The side effect profile for healthy, eligible dogs is broadly comparable to monthly oral prevention in clinical studies. The irreversibility point is real but manageable when the dog is a genuinely good candidate and monitoring is in place. Call your vet’s office, ask for the Client Information Sheet, ask whether your dog meets all the label criteria for a healthy candidate, and ask whether your vet plans to have you stay for observation post-injection. Those three questions will tell you whether the appointment was handled correctly.
If the reaction was serious (vomiting, weakness, facial swelling, collapse), your vet should have documented it and initiated supportive care. Once stabilized, report the adverse event to Zoetis at 1-888-963-8471 and optionally to the FDA’s Center for Veterinary Medicine at 1-888-FDA-VETS. ProHeart is contraindicated in dogs previously found to be hypersensitive — future ProHeart injections are not appropriate for your dog. Monthly oral heartworm prevention using a different drug class (milbemycin oxime, found in Sentinel and Interceptor products, rather than moxidectin) is the standard alternative. Inform every vet your dog sees in the future of the ProHeart reaction — add it to the permanent medical record.
No — the FDA label is unambiguous on this point: ProHeart must not be administered to dogs that are sick, debilitated, underweight, or have a history of unexplained weight loss. This isn’t bureaucratic over-caution. The clinical data showed higher adverse event rates and serious outcomes in dogs with compromised health at the time of injection. Find and address the underlying cause of the weight loss or illness first. When your dog has returned to a stable, healthy body condition and your vet confirms they meet the pre-injection health criteria, ProHeart is back on the table. In the meantime, continue heartworm prevention with a monthly oral option appropriate for your dog’s current condition.
Herding breeds with the MDR1/ABCB1 gene mutation have impaired drug efflux at the blood-brain barrier, making them more susceptible to CNS side effects from moxidectin-class drugs at high doses. The good news: Zoetis specifically conducted an ivermectin-sensitive Collie safety study for ProHeart 12 at 1X, 3X, and 5X the recommended dose — with no clinical signs of moxidectin toxicity at any dose. This is real, published data that provides meaningful reassurance. The nuance: “ivermectin-sensitive” in that study was defined by the dogs’ Collie genetic background, not by individual mutation confirmation. A DNA test (cheek swab, available through Washington State University’s VCPL laboratory or several commercial options) identifies your individual dog’s mutation status and gives you and your vet precise information rather than breed-based inference.
ProHeart is a prescription-only product available only through certified veterinary practices — it cannot be purchased from a pet store or online pharmacy. Here’s what the full visit looks like.
ProHeart is dosed by body weight, so cost scales with your dog’s size. Clinic markups vary widely, but the general ranges based on current market data:
- ProHeart 6 — small dog up to ~25 lbs: ~$40–$55 per injection ($80–$110 annually for two doses)
- ProHeart 6 — medium dog 26–75 lbs: ~$50–$70 per injection ($100–$140 annually)
- ProHeart 6 — large dog 76–100 lbs: ~$70–$90 per injection ($140–$180 annually)
- ProHeart 12 — small dog up to ~25 lbs: ~$60–$80 per injection (annual cost)
- ProHeart 12 — medium dog 26–50 lbs: ~$80–$100 per injection
- ProHeart 12 — large dog 51–75 lbs: ~$120–$140 per injection
- ProHeart 12 — extra large dog 76–100 lbs: ~$150–$175 per injection
These figures do not include the office visit or exam fee, which clinics typically charge separately. Low-cost vaccine clinics and pop-up vet services often offer ProHeart injections without a separate exam fee, at the lower end of these ranges.
- Heartworm antigen test: Required before every administration. A 4Dx or equivalent in-clinic blood panel takes about 10 minutes and checks for both heartworm antigen and common tick-borne disease antibodies simultaneously.
- Health assessment: The vet will take a history, weigh your dog, and perform a physical exam focused on identifying the contraindicated conditions — weight loss, illness, signs of compromised health.
- Client Information Sheet review: The FDA requires this be provided and reviewed at every ProHeart visit — it lists the adverse event profile and what owners should watch for at home.
- The injection itself: Subcutaneous (under-skin) injection, typically at the scruff of the neck or between the shoulder blades. Takes seconds.
- Post-injection observation: Plan to stay at the clinic for at least 20–30 minutes. If you have a high-allergy dog, discuss whether 60 minutes is more appropriate.
This page is for general informational and educational purposes only and does not constitute veterinary medical advice. ProHeart 6 and ProHeart 12 are prescription-only veterinary drugs — they require a licensed veterinarian’s evaluation and prescription and may only be administered by or on the order of a licensed veterinarian. Drug information, including indications, contraindications, adverse events, and efficacy data, is sourced from official FDA-approved prescribing information (DailyMed/NIH), Zoetis product labeling, and peer-reviewed published research; always consult the current official label at dailymed.nlm.nih.gov or fda.gov/animal-veterinary for the most current information. Efficacy and safety data reflect controlled clinical study conditions — individual outcomes may vary. If your dog experiences an adverse reaction, contact your veterinarian immediately; to report an adverse drug event, contact Zoetis at 1-888-963-8471 or the FDA Center for Veterinary Medicine at 1-888-332-8387. In a pet emergency involving possible poisoning, contact the ASPCA Animal Poison Control Center at 1-888-426-4435. This content is not affiliated with, sponsored by, or endorsed by Zoetis or any veterinary practice referenced.